Award

Studies of vitamin A and D

Description: We have previously identified excessive vitamin A intake as a new risk factor for osteoporotic fracture. Our findings have led to a reduction of levels of vitamin A supplementation and food fortification both in the US and within EU. We are now trying to elucidate the molecular mechanisms behind this bone toxicity. Based on a serendipity finding during these investigations, a specific aim is to develop a new drug treatment for osteoporosis and bone metastases. Over the last decade vitamin D deficiency has become a public health problem. This has been shown to depend mainly on new cut-points that were not evidence-based, but also because many dark-skinned immigrants have very low serum levels of 25-hydroxyvitamin D (S-25OHD). These immigrants have neither lower calcium levels nor lower bone mineral density (BMD) than ethnic Scandinavians. These puzzling observations plus the fact that vitamin D supplementation has not lead to improvements in BMD or musculoskeletal symptoms in randomized studies, point to important knowledge gaps. Our aim is to improve the determination of vitamin D deficiency by taking season of blood draw and vitamin D stores in adipose tissue into account, and by analyzing the free S-25OHD and 1,25(OH)2D - in analogy to the measurement of free thyroid hormone T4 and T3 - to determine at what levels effects on PTH, calcium, BMD, and fracture risk can be seen.
Amount: SEK 3,600,000
Funding type: research
Funder scheme: Project grant
Start date: 2018-01-01
End date: 2020-12-31
Investigator: Håkan Melhus (lead)
Institution: Uppsala University
Field: Medicine
Funded outputs count: 0
Funder award ID: 2017-00971
OpenAlex ID: G4331043746